Literature DB >> 31570275

Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease.

Barham K Abu Dayyeh1, Fateh Bazerbachi2, Isabel Graupera3, Andres Cardenas4.   

Abstract

Entities:  

Keywords:  Bariatric; Cirrhosis; Diabetes; Endoscopic bariatric and metabolic therapies; Endoscopy; NAFLD; NASH; Weight loss

Mesh：

Year:  2019        PMID： 31570275     DOI： 10.1016/j.jhep.2019.07.026

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  [Predictive value of body mass index combined with waist circumference for new-onset nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus].

Authors:  Shan Wang; Jian Zhang; Weihuan Zhang; Haitao Wang; Jingyue Hou; Ruixiu Zhang; Hongfen Liu; Shouling Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-11-30

2.  Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis.

Authors:  Fateh Bazerbachi; Eric J Vargas; Monika Rizk; Daniel B Maselli; Taofic Mounajjed; Sudhakar K Venkatesh; Kymberly D Watt; John D Port; Rita Basu; Andres Acosta; Ibrahim Hanouneh; Naveen Gara; Meera Shah; Manpreet Mundi; Matthew Clark; Karen Grothe; Andrew C Storm; Michael J Levy; Barham K Abu Dayyeh
Journal:  Clin Gastroenterol Hepatol       Date:  2020-04-30       Impact factor: 11.382

3.  Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice.

Authors:  Huanqing Gao; Liang Zhou; Yiming Zhong; Zhen Ding; Sixiong Lin; Xiaoting Hou; Xiaoqian Zhou; Jie Shao; Fan Yang; Xuenong Zou; Huiling Cao; Guozhi Xiao
Journal:  Nat Commun       Date:  2022-02-23       Impact factor: 17.694

4.  Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses.

Authors:  Zi-Yuan Zou; Jing Zeng; Tian-Yi Ren; Yi-Wen Shi; Rui-Xu Yang; Jian-Gao Fan
Journal:  J Clin Transl Hepatol       Date:  2021-03-16

5.  A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease.

Authors:  Hassan Ghoz; Veeravich Jaruvongvanich; Reem Matar; Azizullah Beran; Daniel B Maselli; Andrew C Storm; Barham K Abu Dayyeh
Journal:  Clin Transl Gastroenterol       Date:  2020-09       Impact factor: 4.396

6.  Bariatric surgery proves long-term benefit in patients with cirrhosis.

Authors:  Manhal Izzy; Mounika Angirekula; Barham K Abu Dayyeh; Fateh Bazerbachi; Kymberly D Watt
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.